Literature DB >> 22932172

Characteristics of pulmonary inflammation in combined pulmonary fibrosis and emphysema.

Ying Zhao1, Ai Cui, Feng Wang, Xiao-Juan Wang, Xing Chen, Mu-Lan Jin, Ke-Wu Huang.   

Abstract

BACKGROUND: The condition of concomitant upper lobe emphysema and lower lobe fibrosis as identified by computer tomography is known as combined pulmonary fibrosis and emphysema (CPFE). CPFE has distinct clinical characteristics compared with emphysema alone (EA) and idiopathic pulmonary fibrosis (IPF) without emphysema. However, the pulmonary inflammation characteristics of CPFE are not well known, and the differences between CPFE and the other two diseases with regards to pulmonary inflammation need to be explored. The pulmonary inflammatory characteristics were investigated in CPFE patients and compared with EA and IPF.
METHODS: Fraction exhaled nitric oxide (Fe,NO) and differential cell counts, the concentrations of monokine induced by interferon gamma (MIG/CXCL9), interferon-inducible protein 10 (IP-10/CXCL10), and interferon-inducible T cell alpha chemoattractant (I-TAC/CXCL11) were measured in induced sputum obtained from subjects with CPFE (n = 22), EA (n = 22), IPF (n = 14), and healthy volunteers (HV, n = 12). In addition, immunohistochemistry was used to quantify the expression of nitric oxide synthases in alveolar macrophages in 23 lung tissues from patients and control subjects.
RESULTS: The CPFE group had higher alveolar NO than subjects in the EA and HV groups (P = 0.009, P = 0.001, respectively) but not than the IPF group (P > 0.05). Numbers of sputum eosinophils were significantly elevated in CPFE and IPF groups compared with the HV group (P = 0.001, P = 0.008). In contrast, eosinophil counts in EA group did not differ from those in the HV group. Compared with the EA and HV groups, the CPFE group had a lower concentration of I-TAC/CXCL11 in sputum supernatants (P = 0.003, P = 0.004). Immunoreactivity for inducible nitric oxide synthase (iNOS) was higher in the CPFE group than in the EA group (P = 0.018, P = 0.006, respectively).
CONCLUSIONS: The pulmonary inflammation of CPFE group is more similar to IPF group, while the distal airway inflammation is more significant in CPFE and IPF groups than in EA group. Lung eosinophil cell infiltration and high NOS expression in alveolar macrophage might participate in this pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22932172

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

1.  Prevalence and progression of combined pulmonary fibrosis and emphysema in asymptomatic smokers: A case-control study.

Authors:  Kum Ju Chae; Gong Yong Jin; Young Min Han; Yong Seek Kim; Su Bin Chon; Young Sun Lee; Keun Sang Kwon; Hye Mi Choi; David Lynch
Journal:  Eur Radiol       Date:  2015-02-14       Impact factor: 5.315

Review 2.  Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone.

Authors:  Huijin Lin; Shanping Jiang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

3.  Inflammatory signature in lung tissues in patients with combined pulmonary fibrosis and emphysema.

Authors:  William D Cornwell; Cynthia Kim; Alejandra C Lastra; Chandra Dass; Sudhir Bolla; He Wang; Huaqing Zhao; Frederick V Ramsey; Nathaniel Marchetti; Thomas J Rogers; Gerard J Criner
Journal:  Biomarkers       Date:  2018-11-19       Impact factor: 2.658

4.  The role of inducible nitric oxide synthase for interstitial remodeling of alveolar septa in surfactant protein D-deficient mice.

Authors:  Lars Knudsen; Elena N Atochina-Vasserman; Christopher B Massa; Bastian Birkelbach; Chang-Jiang Guo; Pamela Scott; Beat Haenni; Michael F Beers; Matthias Ochs; Andrew J Gow
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-28       Impact factor: 5.464

Review 5.  Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review.

Authors:  Paolo Cameli; Elena Bargagli; Laura Bergantini; Miriana d'Alessandro; Maria Pieroni; Giovanni A Fontana; Piersante Sestini; Rosa Metella Refini
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.